Royal Bank of Canada Lowers ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $35.00
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its price objective decreased by investment analysts at Royal Bank of Canada from $36.00 to $35.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s target price indicates a potential upside […]
More Stories
Ceres Power Holdings plc (OTCMKTS:CPWHF) Sees Significant Drop in Short Interest
Ceres Power Holdings plc (OTCMKTS:CPWHF – Get Free Report) was the recipient of a large decline in short interest in...
Daicel Co. (OTCMKTS:DACHF) Short Interest Down 14.0% in October
Daicel Co. (OTCMKTS:DACHF – Get Free Report) was the target of a significant drop in short interest in the month...
Coq Inu Trading 28.3% Higher Over Last 7 Days (COQ)
Coq Inu (COQ) traded down 3.2% against the U.S. dollar during the one day period ending at 13:00 PM Eastern...
Ocean Protocol (OCEAN) Self Reported Market Cap Reaches $372.19 Million
Ocean Protocol (OCEAN) traded up 7.4% against the U.S. dollar during the one day period ending at 13:00 PM E.T....
Cocos-BCX (COCOS) Price Reaches $0.44
Cocos-BCX (COCOS) traded up 4.3% against the dollar during the 24 hour period ending at 13:00 PM E.T. on November...
Loom Network (LOOM) Trading Up 10.6% This Week
Loom Network (LOOM) traded 5.3% higher against the U.S. dollar during the 24 hour period ending at 13:00 PM Eastern...